Amneal to report fourth quarter and full year 2023 results on march 1, 2024

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nasdaq: amrx) announced today that the company will release its fourth quarter and full year 2023 financial results on friday, march 1, 2024, prior to market open. the company will host a conference call and live webcast with the investment community at 8:30 a.m. eastern time. the financial results and live webcast will be accessible through the investor relations section of the company's website at https://investors.amneal.com.
AMRX Ratings Summary
AMRX Quant Ranking